1 |
cell-free DNA
(2503 times)
|
Neoplasms (679 times)
|
ctDNA (224 times) NGS (208 times) NSCLC (167 times)
|
2005 Circulation DNA: biological implications for cancer metastasis and immunology.
|
2 |
circulating free DNA
(174 times)
|
Neoplasms (83 times)
|
ctDNA (34 times) CTCs (24 times) NSCLC (24 times)
|
2008 Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
|
3 |
cell-free deoxyribonucleic acid
(22 times)
|
Neoplasms (3 times)
|
CTCs (2 times) NETs (2 times) TG (2 times)
|
2012 Cell-free DNA as a measure of transplant injury.
|
4 |
cell-free fetal DNA
(20 times)
|
Obstetrics (9 times)
|
NT (3 times) ASHG (1 time) BORN (1 time)
|
2015 Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer.
|
5 |
cell-free plasma DNA
(14 times)
|
Neoplasms (6 times)
|
EGFR (4 times) NGS (3 times) ddPCR (2 times)
|
2009 Cell-free plasma DNA during Hemodialysis.
|
6 |
cell-free tumor DNA
(12 times)
|
Neoplasms (4 times)
|
CL (1 time) CNV (1 time) CT (1 time)
|
2015 Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
|
7 |
cell-free circulating tumor DNA
(11 times)
|
Neoplasms (8 times)
|
NGS (4 times) aNSCLC (2 times) OS (2 times)
|
2016 Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.
|
8 |
cell-free nucleic acids
(6 times)
|
Biochemistry (1 time)
|
AT (1 time) CAP (1 time) cCR (1 time)
|
2020 [Guiding significance of pathological diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].
|
9 |
circulating free tumor DNA
(4 times)
|
Neoplasms (3 times)
|
EGFR (2 times) NSCLC (2 times) exoNA (1 time)
|
2016 New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies.
|
10 |
cell-free DNA screening
(3 times)
|
Obstetrics (2 times)
|
DSD (1 time) SCA (1 time)
|
2019 The personal utility of cfDNA screening: Pregnant patients' experiences with cfDNA screening and views on expanded cfDNA panels.
|
11 |
circulating fetal DNA
(3 times)
|
Social Medicine (1 time)
|
LOD (2 times) GE (1 time) LOQ (1 time)
|
2005 Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma.
|
12 |
cell-free DNA analysis
(2 times)
|
Gynecology (1 time)
|
ctDNA (1 time)
|
2022 Antenatal screening for chromosomal abnormalities.
|
13 |
cell-free DNA concentration
(2 times)
|
Jurisprudence (1 time)
|
CTCs (1 time) ctKRAS (1 time) LAPC (1 time)
|
2020 Biological variability of cell-free DNA in healthy females at rest within a short time course.
|
14 |
cell-free DNA levels
(2 times)
|
Science (1 time)
|
BPH (1 time) PC (1 time)
|
2008 Effect of cell-free DNA of patients with cardiomyopathy and rDNA on the frequency of contraction of electrically paced neonatal rat ventricular myocytes in culture.
|
15 |
circulating free plasma DNA
(2 times)
|
Genetics, Medical (1 time)
|
NF1 (1 time) PNF (1 time)
|
2021 Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.
|
16 |
circulating-free-deoxyribonucleic-acid
(2 times)
|
Neoplasms (2 times)
|
cCR (1 time) DFA (1 time) LARC (1 time)
|
2020 Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence.
|
17 |
cell free fetal DNA in maternal blood
(1 time)
|
Gynecology (1 time)
|
NIPT (1 time) SNPs (1 time)
|
2016 [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
|
18 |
cell-free DNA fragments
(1 time)
|
Hematology (1 time)
|
---
|
2022 Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma.
|
19 |
Cell-free DNA in blood
(1 time)
|
Medicine (1 time)
|
AUC (1 time)
|
2012 Multiparametric analysis of cell-free DNA in melanoma patients.
|
20 |
cell-free DNA isolated with silica membrane-based
(1 time)
|
Vascular Diseases (1 time)
|
FXII (1 time) MPO (1 time) NETs (1 time)
|
2021 Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA.
|
21 |
cell-free DNA testing
(1 time)
|
Obstetrics (1 time)
|
NPV (1 time) PPV (1 time) SCA (1 time)
|
2023 A systematic review and meta-analysis of cell-free DNA testing for detection of fetal sex chromosome aneuploidy.
|
22 |
Cell-free DNA-based noninvasive prenatal testing
(1 time)
|
Genetics, Medical (1 time)
|
HCPs (1 time) NIPT (1 time)
|
2019 Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers.
|
23 |
cell-free fragments of DNA
(1 time)
|
Hematologic Diseases (1 time)
|
circRNA (1 time) DLBCL (1 time) lncRNA (1 time)
|
2021 Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.
|
24 |
cell-free genomic DNA
(1 time)
|
Veterinary Medicine (1 time)
|
MHC (1 time)
|
2020 A novel technique for retrospective genetic analysis of the response to vaccination or infection using cell-free DNA from archived sheep serum and plasma.
|
25 |
cell-free methylated DNA
(1 time)
|
Gastrointestinal Diseases (1 time)
|
RT (1 time)
|
2022 Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation.
|
26 |
characterization.Cell-free DNA
(1 time)
|
|
DNA (1 time) NGS (1 time) PJI (1 time)
|
2021 Next generation sequencing for pathogen detection in periprosthetic joint infections.
|
27 |
circulating fetal DNA in maternal blood
(1 time)
|
Genital Diseases, Female (1 time)
|
ART (1 time)
|
2018 [Cell-free fetal DNA analysis in maternal plasma as a screening test for trisomy 21 in twin pregnancies].
|
28 |
circulating free amylin DNA
(1 time)
|
Medicine (1 time)
|
NOD (1 time) qPCR (1 time) T1D (1 time)
|
2016 Circulating Differentially Methylated Amylin DNA as a Biomarker of beta-Cell Loss in Type 1 Diabetes.
|
29 |
circulating free/fragments of tumor DNA
(1 time)
|
Pathology (1 time)
|
CTCs (1 time)
|
2016 Application of Liquid Biopsy for Lung Cancer Treatment.
|
30 |
composition of extracellular free DNA
(1 time)
|
Biochemical Phenomena (1 time)
|
---
|
2004 [Extracellular DNA fragments and DNAse activity in blood serum of rats with transplantated Guerin's carcinoma after multiple exposures to low doses of X-irradiation].
|
31 |
detect free DNA
(1 time)
|
Genetics, Medical (1 time)
|
FISH (1 time) NIPT (1 time) SNP-array (1 time)
|
2021 [Non-invasive prenatal testing and genetic diagnosis of a case of Pallister-Killian syndrome].
|
32 |
extracellular free DNA
(1 time)
|
Pediatrics (1 time)
|
AUC (1 time) CAP (1 time) CRP (1 time)
|
2019 [Significance of neutrophil extracellular trap and its markers in the early diagnosis of community-acquired pneumonia in children].
|
33 |
Graft-cell-free DNA
(1 time)
|
|
ds-cfDNA (1 time) InDel (1 time) ROC (1 time)
|
2023 Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation.
|